Synmosa Biopharma Corporation (4114)
TWSE
Closed
Aug 25, 2026
Day's Range
29.9052 wk Range
27.55Overview - 4114 - Synmosa Biopharma Corporation
Key Statistics
Valuation
Enterprise Value
18.33B
P/E (Trailing)
‪19.02‬
P/E (Forward)
‪12.98‬
PEG Ratio
‪-0.98‬
Price / Sales (TTM)
‪2.31‬
Price / Book
‪1.89‬
EV / EBITDA
‪17.69‬
Profitability
Gross Margin
‪42.32%‬
Profit Margin
‪12.38%‬
Operating Margin
‪11.63%‬
Return on Assets
‪3.04%‬
Return on Equity
‪5.91%‬
Ownership
Shares Outstanding
543.35M
Float
413.84M
Held by Insiders
‪23.21%‬
Held by Institutions
‪4.34%‬
Price stats
50-Day Avg
‪29.54‬
200-Day Avg
‪29.35‬
Dividends
Payout Ratio
‪37.21%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 4114 - Synmosa Biopharma Corporation
Peers - 4114 - Synmosa Biopharma Corporation
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
Profile Summary - 4114 - Synmosa Biopharma Corporation
About
Synmosa Biopharma Corporation is a specialty pharmaceutical company headquartered in Taiwan, recognized for its comprehensive involvement in the healthcare sector. The company specializes in the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, including prescription…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
